Cited by

• Ganglioside SSEA-4 in Ewing sarcoma marks a tumor cell population with aggressive features and is a potential cell-surface immune target.

  Jamitzky S, Altvater B, Krekeler C, Hoen L, Brandes C, Ebbinghaus J, Richter L, Kosel L, Ochs L, Farwick N, Urban K, Kluge L, Bücker L, Görlich D, Johnston ICD, Pfeifer R, Hartmann W, Rossig C, Kailayangiri S. Jamitzky S, et al. Sci Rep. 2024 May 24;14(1):11935. doi: 10.1038/s41598-024-62849-8. Sci Rep. 2024. PMID: 38789477 Free PMC article.
• Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo.

  Bister A, Ibach T, Haist C, Gerhorst G, Smorra D, Soldierer M, Roellecke K, Wagenmann M, Scheckenbach K, Gattermann N, Wiek C, Hanenberg H. Bister A, et al. Mol Ther Oncolytics. 2022 Jun 6;26:120-134. doi: 10.1016/j.omto.2022.05.012. eCollection 2022 Sep 15. Mol Ther Oncolytics. 2022. PMID: 35795096 Free PMC article.
• [Adoptive T-cell therapy of rhabdomyosarcoma].

  Simon-Keller K, Paschen A, Eichmüller S, Gattenlöhner S, Barth S, Koscielniak E, Leuschner I, Stöbel P, Hombach A, Abken H, Marx A. Simon-Keller K, et al. Pathologe. 2010 Oct;31 Suppl 2:215-20. doi: 10.1007/s00292-010-1344-8. Pathologe. 2010. PMID: 20730458 German.
• Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia.

  Portell CA, Wenzell CM, Advani AS. Portell CA, et al. Clin Pharmacol. 2013 Apr 12;5(Suppl 1):5-11. doi: 10.2147/CPAA.S42689. Print 2013. Clin Pharmacol. 2013. PMID: 23671399 Free PMC article.
• New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future.

  Biagi E, Marin V, Attianese GM, Pizzitola I, Tettamanti S, Cribioli E, Biondi A. Biagi E, et al. Ital J Pediatr. 2011 Sep 22;37:46. doi: 10.1186/1824-7288-37-46. Ital J Pediatr. 2011. PMID: 21939556 Free PMC article. Review.